PRESS RELEASE published on 10/10/2023 at 07:00, 1 year 1 month ago Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA)
PRESS RELEASE published on 10/02/2023 at 07:00, 1 year 1 month ago Cosmo and Hikma Sign License Agreement for Winlevi® in 17 Middle Eastern and North African Countries
PRESS RELEASE published on 09/27/2023 at 07:00, 1 year 1 month ago Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa
PRESS RELEASE published on 09/04/2023 at 07:00, 1 year 2 months ago Cosmo and Adalvo sign License and Supply Agreement for Rifamycin SV MMX® 200mg in Europe, APAC, MENA and LATAM regions
PRESS RELEASE published on 09/04/2023 at 06:45, 1 year 2 months ago Termination of Agreement for Rifamycin SV MMX® with Dr. Falk Pharma
PRESS RELEASE published on 07/26/2023 at 06:00, 1 year 3 months ago Cosmo presents strong H1 2023 operational and financial results
PRESS RELEASE published on 07/05/2023 at 07:15, 1 year 4 months ago Invitation to Cosmo’s Half-Year 2023 Webcast on 26 July 2023
PRESS RELEASE published on 06/29/2023 at 07:15, 1 year 4 months ago Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia
PRESS RELEASE published on 06/28/2023 at 07:15, 1 year 4 months ago Cosmo announces Cortiment® approval in Japan
PRESS RELEASE published on 06/22/2023 at 07:15, 1 year 4 months ago Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea
Published on 11/21/2024 at 13:00, 26 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 26 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 26 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 26 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 26 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 51 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 11 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 28 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 6 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 41 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 41 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
